TrialNeurology(R) neuroimmunology & neuroinflammation2020

Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.

Heinz Wiendl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.